1. Home
  2. HLN vs GMAB Comparison

HLN vs GMAB Comparison

Compare HLN & GMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

SELL

Current Price

$9.19

Market Cap

38.5B

ML Signal

SELL

Logo Genmab A/S ADS

GMAB

Genmab A/S ADS

SELL

Current Price

$51.57

Market Cap

31.9B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HLN
GMAB
Founded
2022
1999
Country
United Kingdom
Denmark
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.5B
31.9B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
HLN
GMAB
Price
$9.19
$51.57
Analyst Decision
Buy
Strong Buy
Analyst Count
5
12
Target Price
$10.40
★ $65.01
AVG Volume (30 Days)
★ 22.5M
6.3M
Earning Date
07-30-2026
11-05-2026
Dividend Yield
★ 2.16%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.35
$27.61
Revenue Next Year
$3.29
$21.18
P/E Ratio
$49.05
★ $1.90
Revenue Growth
N/A
N/A
52 Week Low
$8.38
$23.62
52 Week High
$11.28
$59.97

Technical Indicators

Market Signals
Indicator
HLN
GMAB
Relative Strength Index (RSI) 47.60 59.86
Support Level $9.08 $25.91
Resistance Level $9.32 $59.97
Average True Range (ATR) 0.19 3.02
MACD -0.01 -0.70
Stochastic Oscillator 48.33 47.44

Price Performance

Historical Comparison
HLN
GMAB

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

About GMAB Genmab A/S ADS

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

Share on Social Networks: